Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$4.21
-1.15%
Mkt Cap $14.65M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$125.00
Range $125.00 – $125.00
Implied Upside
+2868.3%
Consensus $125.00 vs current $4.21